this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization
Bio Photo

Home
About BIO
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
National Issues
Health Care
Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Conferences & Events
Business & Finance


Friday, May 09, 2008

Capital Formation

statement of purposebusiness development &
investor relations events
public policykey issue: sarbanes-oxley
key issue: sbirresources

NASDAQ Biotechnology Index:
797.06 up 0.64
information delayed 15 min.
Details (NASDAQ.com)

Capital Formation and Emerging Companies
Statement of Purpose

The capital formation and the business needs of small to medium-size member companies are a high priority at BIO. To address these needs and concerns, the Board of Directors has established the Emerging Companies Section, a committee with its own governing body and approximately one-third of the seats on the Board of Directors. Its primary roles are

  • To review the major public policy issues confronting the industry and make sure the BIO position reflects the interests of small and medium-sized companies
  • To look for opportunities through legislation and regulatory reform to help emerging companies with core activities such as capital formation
  • To recommend services and programs useful in supporting business development and financing requirements of small and medium-sized companies

Services provided by the ECS include (but are not limited to) a global range of investor and partnering conferences, executive education and training, and BIO BUSINESS SOLUTIONSsm, providing lower costs on products and services such as lab products, business insurance, employee benefits and office equipment and supplies.




© 2008 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024